Inspire Medical Systems Earnings Preview: Analyst Estimates and Historical Performance

Inspire Medical Systems is set to announce its quarterly earnings on August 4, 2025. Analysts estimate an EPS of $0.21. Historically, the company has beaten EPS estimates and seen a 1.98% increase in share price. Inspire Medical Systems has received a total of 6 ratings from analysts, with a consensus rating of Outperform and a potential 58.45% upside.

Inspire Medical Systems (INSP) is set to announce its quarterly earnings on August 4, 2025. Analysts estimate an EPS of $0.21, which represents a year-over-year decline of -31.3% [1]. While revenues are expected to increase by 9.8% to $215.05 million, the earnings outlook indicates a challenging quarter for the company.

Historically, Inspire Medical Systems has a track record of beating EPS estimates. In the last reported quarter, the company delivered an EPS surprise of +143.48%, beating expectations by $0.33 [1]. This performance was followed by a 1.98% increase in share price the next day. Over the last four quarters, the company has beaten consensus EPS estimates four times.

Analysts have given Inspire Medical Systems a consensus rating of Outperform, with an average one-year price target of $197.33, suggesting a potential 58.45% upside [2]. The company ranks at the top for revenue growth and gross profit among its peers, but it has the lowest return on equity [2].

Inspire Medical Systems operates as a medical technology company, focusing on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's Inspire system is a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

The company's market capitalization is positioned below industry averages, which could be attributed to factors such as growth expectations or operational capacity [2]. Revenue growth for the company was approximately 22.75% as of 31 March 2025, indicating a notable increase in top-line earnings.

Investors should pay attention to other factors beyond the earnings beat or miss, as these are not the sole determinants of a stock's performance. The company's Earnings ESP of +9.09% and Zacks Rank of #3 suggest that Inspire is likely to beat the consensus EPS estimate [1]. However, the sustainability of the immediate price change and future earnings expectations will depend on management's discussion of business conditions on the earnings call.

References:
[1] https://finance.yahoo.com/news/inspire-medical-systems-insp-expected-140013342.html
[2] https://www.benzinga.com/insights/earnings/25/08/46800844/uncovering-potential-inspire-medical-systemss-earnings-preview